Curative Biosciences, Inc. (CBDX) financial statements (2022 and earlier)

Company profile

Business Address 5042 WILSHIRE BLVD.
LOS ANGELES, CA 90036
State of Incorp. NV
Fiscal Year End June 30
SIC 209 - Miscellaneous Food Preparations And Kindred (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

3/31/2018
Q3
12/31/2017
Q2
9/30/2017
Q1
6/30/2017
Q4
3/31/2017
Q3
12/31/2016
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1     
Cash and cash equivalents1     
Total current assets:1     
Noncurrent Assets
Property, plant and equipment012234
Intangible assets, net (including goodwill)13     
Intangible assets, net (excluding goodwill)13     
Total noncurrent assets:1312234
TOTAL ASSETS:1412234
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities180180186188354353
Accounts payable170170176177162161
Accrued liabilities777777
Employee-related liabilities444444
Taxes payable    182182
Debt15611180636159
Estimated litigation liability201201201201201201
Other undisclosed current liabilities182182182182  
Total current liabilities:720675649633616613
Noncurrent Liabilities
Total liabilities:720675649633616613
Stockholders' equity
Stockholders' equity attributable to parent(706)(674)(648)(631)(613)(609)
Common stock202016161616
Additional paid in capital52,93752,93752,51652,51652,51652,516
Accumulated deficit(53,663)(53,631)(53,179)(53,162)(53,144)(53,140)
Total stockholders' equity:(706)(674)(648)(631)(613)(609)
TOTAL LIABILITIES AND EQUITY:1412234

Income statement (P&L) ($ in thousands)

3/31/2018
Q3
12/31/2017
Q2
9/30/2017
Q1
6/30/2017
Q4
3/31/2017
Q3
12/31/2016
Q2
Operating expenses(32)(452)(17)(18)(4)(7)
Other undisclosed operating income 903  814
Operating income (loss):(32)452(17)(18)47
Net income (loss) available to common stockholders, diluted:(32)452(17)(18)47

Comprehensive Income ($ in thousands)

3/31/2018
Q3
12/31/2017
Q2
9/30/2017
Q1
6/30/2017
Q4
3/31/2017
Q3
12/31/2016
Q2
Net income (loss):(32)452(17)(18)47
Comprehensive income (loss), net of tax, attributable to parent:(32)452(17)(18)47

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: